期刊文献+

基质金属蛋白酶及其抑制剂与咽喉部黑色素瘤浸润和转移的分子机制 被引量:1

Expressions of Matrix Metalloproteinase 2(MMP-2) and Tissue Inhibitor of Metalloproteinase 2(TIMP-2) and their Correlation with molecular-mechanism of invasion and metastasis in laryngopharyngeal malignant melanoma
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶(MM P-2)及组织基质金属蛋白酶抑制剂(T IM P-2)在咽喉部恶性黑色素瘤中的表达及其在肿瘤浸润转移中的作用。方法:将28例咽喉部恶性黑色素瘤样本按照微血管密度和K i-67标记指数分别分为高度恶性和低度恶性2组,并进行MM P-2及T IM P-2免疫组化染色。结果:(1)微血管计数>36.5的肿瘤组中MM P-2阳性表达率高于微血管计数<36.5的肿瘤组;而T IM P-2阳性表达率低于微血管计数<36.5的肿瘤组,两组差异有显著性(P<0.05);(2)K i-67标记指数>22.5的肿瘤组中MM P-2阳性表达率高于K i-67标记指数<22.5的肿瘤组;而T IM P-2阳性表达率低于K i-67标记指数<22.5的肿瘤组,两组差异有显著性(P<0.05)。结论:肿瘤浸润转移相关蛋白在肿瘤的浸润转移过程中作用各不相同,MM P-2促进了肿瘤的浸润转移,而T IM P-2抑制肿瘤的浸润转移。 Objective .. To study the expressions of Matrix Metalloproteinase 2 and Tissue Inhibitor of Metalloproteinase 2 and their Correlation with molecular-mechanism of invasion and metastasis in malignant melanoma. Methods:28 cases of malignant melanoma were divided into high and low grade groups according to the MVD and Ki-67 ,MMP-2 and TIMP-2 were detected by immunohistoehemieal staining. Results:Expressions of MMP-2 in high grade malignant melanoma group were higher than those in low grade group. Expressions of TIMP-2 in low grade malignant melanoma group were higher than those in high grade group. There were statistical significance of MMP-2 and TIMP-2 expressions between high and low grade malignantmelanoma (P^01 05). Conclusion..Invasion and metastasis related proteins exerted different functions in the invasion and metastasis of tumors. MMP-2 could accelerate invasion and metastasis in tumors, but TIMP-2 inhibit the process.
出处 《中国误诊学杂志》 CAS 2006年第15期2863-2866,共4页 Chinese Journal of Misdiagnostics
关键词 咽肿瘤/病理学 黑色素瘤 明胶酶A/代谢 金属蛋白酶2组织抑制剂/代谢 免疫组织化学 Pharyngeal neoplasms/pathology Melanoma Gelatinase A/metabolism Tissue inhibitor of metalloproteinase-2/metabolism Immunohistoehemistry
  • 相关文献

参考文献4

二级参考文献14

共引文献53

同被引文献20

  • 1Gomez DE, Alonso DF, Yoshiji H, et al. Tissue Inhibitor of metalloproteinases : structure, regulation and hiological functions [ J ]. Eur J Cell Biol, 1997,74 (2) : 111-122.
  • 2Gohji K, Fujimoto N, Ohkawa J, et al. Imbalance between serum matrix[J]. Br J Cancer, 1998,77(4) :650-655.
  • 3Still K, Robson CN, Autzen P, et al. Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 ( TIMP-2 ) in human benign and malignant prostatic tissue [ J ]. Prostate, 2000,42 ( 1 ) : 18 -25.
  • 4Ara T, Kusafuka T, Inoue M, et al. Determination of imbalance between MMP-2 and TIMP-2 in human neuroblastoma by reverse- transcription polymerase chain reaction and its correlation with tumor progression[ J]. J Pediatr Surg,2000,35 (3) :432-437.
  • 5Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases inmetastasis [ J ]. J Natl Cancer Inst, 1997,89 (17) :1260-1270.
  • 6Kraiem Z, Korem S. Matrix metalloproteinases and the thyroid [ J ]. Thyroid,2000,10(12) : 1061-1069.
  • 7Schonherr E, Schaefer L, O'Connell BC, et al. Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression [ J ]. J Cell Physiol,2001,187 ( 1 ) : 37-47.
  • 8Guo H,Li R, Zucker S, et al. EMMPRIN (CD147 ) , an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface[J]. Cancer Res,2000, 60(4) :888- 891.
  • 9Yoshizaki T, Sato H, Furukawa M. Recent advances in the regulation of matrix metalloproteinase 2 activation:from basic research to clinical implication [ J ]. Oncol Rep,2002,9 ( 3 ) :607-611.
  • 10Katayama A, Bandoh N, Kishibe K, et al. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis [ J ]. Clin Cancer Res,2004,10(2) :634-640.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部